Current approaches to pathogenetic support of thyroid function: the role of myo-inositol, selenium, and vitamin D

November 16, 2026
329
УДК:  УДК 616.441-08
Resume

Thyroid disorders, particularly autoimmune thyroiditis and subclinical hypothyroidism, remain a significant issue in modern endocrinology, necessitating the refinement of approaches for the pathogenetically grounded support of thyroid function. This review aims to summarize current data on the roles of myo-inositol, selenium, and vitamin D in the regulation of thyroid homeostasis, as well as to evaluate the outcomes of their combined use. Myo-inositol participates in the phosphoinositide signaling pathway of the thyroid-stimulating hormone (TSH) receptor and in metabolic processes related to insulin sensitivity. Selenium facilitates the function of iodothyronine deiodinases and antioxidant enzymes, while vitamin D is involved in regulating the immune response. Clinical studies have demonstrated that the use of a combination of myo-inositol and selenium can reduce TSH levels in patients with subclinical hypothyroidism associated with autoimmune thyroiditis. A Ukrainian study on the combined use of myo-inositol, selenium, and vitamin D also revealed favorable changes in specific markers of thyroid autoimmunity and pro-inflammatory cytokines. Three-component agents — specifically the dietary supplement Myoseldin — are of practical interest; its composition has a pathophysiological rationale and may be considered a promising approach for the adjunctive support of thyroid function.

References

  • 1. Pearce S.H.S., Brabant G., Duntas L.H. et al. (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J., 2(4): 215–228. doi: 10.1159/000356507.
  • 2. Cicatiello A.G., Di Girolamo D., Dentice M. (2018) Metabolic effects of the intracellular regulation of thyroid hormone: old players, new concepts. Front. Endocrinol., 9: 474. doi: 10.3389/fendo.2018.00474.
  • 3. Benvenga S., Nordio M., Laganà A.S. et al. (2021) The role of inositol in thyroid physiology and in subclinical hypothyroidism management. Front. Endocrinol., 12: 662582. doi: 10.3389/fendo.2021.662582.
  • 4. Delavar M.A., Mirabi P., Rosenkranz S.K. et al. (2025) Inositol supplementation efficacy in improving key cardiometabolic and anthropometric indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Diabetol. Metab. Syndr., 17(1): 411. doi: 10.1186/s13098-025-01980-6.
  • 5. Nordio M., Basciani S., Camajani E. (2019) The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur. Rev. Med. Pharmacol. Sci., 23(12): 5512–5521. doi: 10.26355/eurrev_201906_18223.
  • 6. Ventura M., Melo M., Carrilho F. (2017) Selenium and thyroid disease: from pathophysiology to treatment. Int. J. Endocrinol., 2017: 1297658. doi: 10.1155/2017/1297658.
  • 7. Hu Y., Feng W., Chen H. et al. (2021) Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto’s thyroiditis: a prospective randomized-controlled trial. Clin. Transl. Sci., 14(4): 1390–1402. doi: 10.1111/cts.12993.
  • 8. Wichman J., Winther K.H., Bonnema S.J. et al. (2016) Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid, 26(12): 1681–1692. doi: 10.1089/thy.2016.0256.
  • 9. van Zuuren E.J., Albusta A.Y., Fedorowicz Z. et al. (2013) Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst. Rev., 6: CD010223. doi: 10.1002/14651858.CD010223.pub2.
  • 10. Babić Leko M., Jureško I., Rozić I. et al. (2023) Vitamin D and the thyroid: a critical review of the current evidence. Int. J. Mol. Sci., 24(4): 3586. doi: 10.3390/ijms24043586.
  • 11. Sun W., Ding C., Wang Y. et al. (2025) Vitamin D deficiency in Hashimoto’s thyroiditis: mechanisms, immune modulation, and therapeutic implications. Front. Endocrinol., 16: 1576850. doi: 10.3389/fendo.2025.1576850.
  • 12. Bendotti G., Mele C., Costantini L. et al. (2026) The role of vitamin D in autoimmune thyroid diseases: from immunomodulation to clinical implications. Nutrients, 18(2): 217. doi: 10.3390/nu18020217.
  • 13. Nordio M., Pajalich R. (2013) Combined treatment with myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J. Thyroid Res., 2013: 424163. doi: 10.1155/2013/424163.
  • 14. Nordio M., Basciani S. (2017) Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto’s patients with subclinical hypothyroidism. Eur. Rev. Med. Pharmacol. Sci., 21(2): 51–59.
  • 15. Payer J., Jackuliak P., Kužma M. et al. (2022) Supplementation with myo-inositol and selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism. Front. Endocrinol., 13: 1067029. doi: 10.3389/fendo.2022.1067029.
  • 16. Zuhair V., Sheikh A.T., Shafi N. et al. (2024) Role of supplementation with selenium and myo-inositol versus selenium alone in patients of autoimmune thyroiditis: a systematic review and meta-analysis. Clin. Med. Insights Endocrinol. Diabetes, 17: 11795514241300998. doi: 10.1177/11795514241300998.
  • 17. Stanchev P., Kraeva M., Petrov P.-P. et al. (2026) Myo-inositol plus selenium vs. selenium alone in Hashimoto’s thyroiditis with subclinical hypothyroidism: a systematic review and updated meta-analysis with trial sequential analysis. J. Clin. Med., 15(9): 3179. doi: 10.3390/jcm15093179.
  • 18. Пасєчко Н.В., Кульчінська В.М. (2023) Вплив комплексного застосування міо-інозитолу, вітаміну D та селену на цитокіновий статус жінок репродуктивного віку з автоімунним тиреоїдитом. Міжнародний ендокринологічний журнал, 19(3): 188–193. doi: 10.22141/2224-0721.19.3.2023.1270.